THE USE OF GENERIC MOXONIDINE IN SYSTEMIC BLOOD PRESSURE ELEVATION
https://doi.org/10.15829/1728-8800-2015-4-13-17
Abstract
Aim. To evaluate the opportunities of the Tenzotran generic moxonidine for urgent care in non-life-threatening blood pressure (BP) increase; to check the efficacy, safety and duration of sufficient effect onset. Material and methods. The study is performed in pre-hospital stage with participation of 53 patients with BP increase, non-life- threatening. The 1st group consisted of the patients with clinical signs of hyper sympathetic activity, the 2nd — patients with the signs mentioned.
Moxonidine generic was prescribed sublingually once in dosage 0,4 mg. Then the signs were collected for increased sympathic activity, BP, heart rate, localization and severity of headache, adverse events.
Results. In emergency care Tenzotran effectively decreases blood pressure ad relieves headache in patients with the signs of increased sympathetic tone. Adverse events after Tenzotran use are not severe and are rare. Conclusion. Confirmed effectiveness and safety make it possible to recommend moxonidine generic Tenzotran for emergent care in BP increase that is non-life-threatening, in outpatient care.
About the Authors
B. B. Ruksin
1North-Western State Medical University n.a. I. M. Mechnikov. Saint-Petersburg, Russia;
Russian Federation
Russian Federation
O. B. Grishin
Polyclinics №17. Saint-Petersburg, Russia;
Russian Federation
Russian Federation
S. V. Yashchenkova
Polyclinics №8. Saint-Petersburg, Russia
Russian Federation
Russian Federation
М. В. Onuchin
Polyclinics №8. Saint-Petersburg, Russia
Russian Federation
Russian Federation
References
1. elevation of the blood pressure, and differential prehospital therapies. Emergency medical care 2009; 10 (2): 11-21. Russian (Руксин В. В., Гришин О. В., Соколов Ю. В. и др. Особенности неотложных состояний, связанных с повышением артериального давления, и дифференцированный подход к оказанию скорой медицинской помощи. Скорая медицинская помощь 2009; 10 (2): 11-21).
2. Ruksin VV, Grishin OV, Kuznetsov AV, et al. Comparison of the efficacy and safety of clonidine and moxonidine for emergency care. Emergency medical care 2009; 10 (4): 13-20. Russian (Руксин В. В., Гришин О. В., Кузнецов А. В. и др. Сравнение эффективности и безопасности клонидина и моксонидина для оказания неотложной поомощи. Скорая медицинская помощь 2009; 10 (4): 13-20).
3. Tereshchenko SN, Gaponova NI, Abdrakhmanov VR, et al. Randomized comparative study of the moxonidine effectiveness in patients with uncomplicated hypertensive crisis (AVES). Arterial'naya gipertenziya 2011; 7(4): 316-24. Russian (Терещенко С. Н., Гапонова Н. И., Абдрахманов В. Р. и др. Рандомизированное
4. многоцентровое сравнительное исследование эффективности моксонидина у больных с неосложненным гипертоническим кризом (AVES). Артериальная гипертензия 2011; 7(4): 316-24).
5. Chazova IE, Ratova LG, Boytsov SA, et al. Diagnosis and treatment of arterial hypertension (Guidelines on diagnostics and management of arterial hypertension of Russian Medical Society of Arterial Hypertension and All-Russian Society of Cardiology. System Hypertension 2010; 3: 5-27. Russian (Чазова И. Е., Ратова Л. Г., Бойцов С. А. и др. Диагностика и лечение артериальной гипертензии (Рекомендации Российского медицинского общества по артериальной гипер¬тонии и Всероссийского научного общества кардиологов). Системные гипер- тензии 2010; 3: 5-27).
6. Battegay E, Lip G, Bakris G. Hypertensive emergencies and urgencies: Uncontrolled severe hypertension. Hypertension-Principles and Practice 2005; 651-69.
7. MacNab I. Negative disc exploration: an analysis of the cause of nerve root involvement in sixty-eight patients. J Bone Joint Surg 1971; 53: 891-903.
Review
For citations:
Ruksin B.B., Grishin O.B., Yashchenkova S.V., Onuchin М.В. THE USE OF GENERIC MOXONIDINE IN SYSTEMIC BLOOD PRESSURE ELEVATION. Cardiovascular Therapy and Prevention. 2015;14(4):13-17. (In Russ.) https://doi.org/10.15829/1728-8800-2015-4-13-17
Views:
1131
Email this article 
